0000896262-21-000049.txt : 20210302
0000896262-21-000049.hdr.sgml : 20210302
20210302200143
ACCESSION NUMBER: 0000896262-21-000049
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210226
FILED AS OF DATE: 20210302
DATE AS OF CHANGE: 20210302
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ginn Scott G
CENTRAL INDEX KEY: 0001543701
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-24260
FILM NUMBER: 21706386
MAIL ADDRESS:
STREET 1: 3854 AMERICAN WAY
STREET 2: SUITE A
CITY: BATON ROUGE
STATE: LA
ZIP: 70816
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AMEDISYS INC
CENTRAL INDEX KEY: 0000896262
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HOME HEALTH CARE SERVICES [8082]
IRS NUMBER: 113131700
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3854 AMERICAN WAY
STREET 2: SUITE A
CITY: BATON ROUGE
STATE: LA
ZIP: 70816
BUSINESS PHONE: 2252922031
MAIL ADDRESS:
STREET 1: 3854 AMERICAN WAY
STREET 2: SUITE A
CITY: BATON ROUGE
STATE: LA
ZIP: 70816
FORMER COMPANY:
FORMER CONFORMED NAME: ANALYTICAL NURSING MANAGEMENT CORP
DATE OF NAME CHANGE: 19940819
FORMER COMPANY:
FORMER CONFORMED NAME: M&N CAPITAL CORP
DATE OF NAME CHANGE: 19930125
4
1
wf-form4_161473328516040.xml
FORM 4
X0306
4
2021-02-26
0
0000896262
AMEDISYS INC
AMED
0001543701
Ginn Scott G
3854 AMERICAN WAY, SUITE A
BATON ROUGE
LA
70816
0
1
0
0
EVP & Chief Financial Officer
Common Stock
2021-02-26
4
M
0
975
27.35
A
30084
D
Common Stock
2021-02-26
4
S
0
975
264.15
D
29109
D
Common Stock
2714
I
Through 401(k) Plan
Stock Option (Right to Buy)
27.35
2021-02-26
4
M
0
975
0
D
2025-05-01
Common Stock
975.0
2925
D
The total amount of shares beneficially owned includes 887 shares held in an employee stock purchase plan account.
These sales were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.
The information in this report is based on a plan statement dated as of December 31, 2020.
On May 1, 2015, the reporting person was granted an option to purchase 22,500 shares of common stock. The option vests based on the Issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2015, 2016, 2017 and 2018. The performance criteria for 2018 were met, resulting in vesting of the option as to 5,625 shares (the "2018 Tranche Options"), subject to additional time-based vesting as follows: one-third of the 2018 Tranche Options vested on May 1, 2019 and two-thirds of the 2018 Tranche Options vested on May 1, 2020. After the transactions reported in this Form 4, 2,925 of the 2018 Tranche Options remain unexercised.
/s/ Jennifer R. Guckert, pursuant to a power of attorney
2021-03-02